{
    "Trade/Device Name(s)": [
        "FORA ADVANCED GD40 Glucose, \u03b2-Ketone and Cholesterol Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K201037",
    "Predicate Device Reference 510(k) Number(s)": [
        "K161738",
        "K163406"
    ],
    "Regulatory Class": "Class II (glucose test); Class I, meets limitations of exemption (\u03b2-ketone and cholesterol tests)",
    "Product Code(s)": [
        "NBW",
        "JIN",
        "CHH"
    ],
    "Summary Letter Date": "February 24, 2022",
    "Summary Letter Received Date": "March 1, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Glucose",
        "\u03b2-Hydroxybutyrate",
        "Cholesterol"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (finger)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FORA ADVANCED GD40 Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Enzymatic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for FORA ADVANCED GD40 system for quantitative measurement of glucose, \u03b2-ketone, and cholesterol in capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose, \u03b2-hydroxybutyrate (\u03b2-ketone), and cholesterol in fresh capillary whole blood from the finger for single-patient home use by patients with diabetes; glucose and \u03b2-ketone for diabetes control monitoring, cholesterol for diagnosis/treatment of lipid metabolism disorders.",
    "fda_folder": "Clinical Chemistry"
}